InsiderTrades

Form 4 for JNJ Johnson & Johnson

Accepted 2026-09-04 09:08:07 ET · period of report 2026-09-02 · accession 0000200406-26-000179 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-09-04 09:08 2026-09-02 JNJ Schmid Timothy EVP, WW COB, MedTech M - OptEx $144.99 +33.6K 48.0K +234% +$4.87M
DM 2026-09-04 09:08 2026-09-02 JNJ Schmid Timothy EVP, WW COB, MedTech S - Sale+OE $274.74 -33.6K 25.4K -57% -$9.23M
DM 2026-09-04 09:08 2026-09-02 JNJ Schmid Timothy EVP, WW COB, MedTech M - OptEx $0.00 -33.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-02 M A 11,070 $131.94 36,517 D — —
2 Common Common Stock 2026-09-02 S D 11,070 $274.74 25,447 D — —
3 Common Common Stock 2026-09-02 M A 22,527 $151.41 47,974 D — —
4 Common Common Stock 2026-09-02 S D 22,527 $274.74 25,447 D — —
5 Derivative Employee Stock Options (Right to Buy) 2026-09-02 M D 11,070 $0.00 0 D $131.94 · 2022-02-11 to 2029-02-11 11,070 Common Stock (F3) Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
6 Derivative Employee Stock Options (Right to Buy) 2026-09-02 M D 22,527 $0.00 0 D $151.41 · 2023-02-10 to 2030-02-10 22,527 Common Stock (F3) Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.